Get data from any page you want to get data from.
Need to talk to someone? Contact us—we’d love to help.
Get data from any page you want to get data from.
Need to talk to someone? Contact us—we’d love to help.
We are still busy preparing this batch of data. Please come back in a few minutes.
Seems like this data source was never ran before...
Changes are only available only when you have ran at least a second time.
Nope... guess no Martians around... Maybe set the webhook URL before pressing this button again...
newsreleaseconsolidatelink display-outline w-100-href | h3 | remove-outline | small | no-top-margin remove-outline | langspan | Headline | Column 2 | date | content | Headline | Date | headline | url | content | Column 10 | origin_pattern | origin_url | createdAt | updatedAt | pingedAt |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
https://www.prnewswire.com/news-releases/100-cbr-fda-granted-odd-to-biostar-pharm... | 21 MAR, 2024, 08:30 ET 100% CBR! FDA Granted ODD to Biostar Pharma's Utidelone Ca... | Biostar Pharma, Inc., the U.S. subsidiary of Beijing Biostar Pharmaceuticals Co.,... | 21 MAR, 2024, 08:30 ET | 21 MAR, 2024, 08:30 ET 100% CBR! FDA Granted ODD to Biostar Pharma's Utidelone Ca... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | |||||||||||
https://www.prnewswire.com/news-releases/111-inc-announces-fourth-quarter-and-fis... | 21 MAR, 2024, 04:47 ET 111, Inc. Announces Fourth Quarter and Fiscal Year 2023 Fi... | 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcar... | 21 MAR, 2024, 04:47 ET | 21 MAR, 2024, 04:47 ET 111, Inc. Announces Fourth Quarter and Fiscal Year 2023 Fi... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | |||||||||||
https://www.prnewswire.com/news-releases/accent-therapeutics-to-present-data-supp... | 21 MAR, 2024, 08:00 ET Accent Therapeutics to Present Data Supporting DHX9 and KI... | Accent Therapeutics, a biopharmaceutical company pioneering a new class of small ... | 21 MAR, 2024, 08:00 ET | 21 MAR, 2024, 08:00 ET Accent Therapeutics to Present Data Supporting DHX9 and KI... | Accent Therapeutics, a biopharmaceutical company pioneering a new class of small ... | 21 MAR, 2024, 08:00 ET Accent Therapeutics to Present Data Supporting DHX9 and KI... | 21 MAR, 2024, 08:00 ET | 21 MAR, 2024, 08:00 ET Accent Therapeutics to Present Data Supporting DHX9 and KI... | Accent Therapeutics, a biopharmaceutical company pioneering a new class of small ... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/american-society-of-pharmacovigilance-am... | 20 MAR, 2024, 08:44 ET American Society of Pharmacovigilance Amplifies Coordinate... | Almost one million Americans have died of adverse drug events, many avoidable, in... | 20 MAR, 2024, 08:44 ET | 20 MAR, 2024, 08:44 ET American Society of Pharmacovigilance Amplifies Coordinate... | Almost one million Americans have died of adverse drug events, many avoidable, in... | 20 MAR, 2024, 08:44 ET American Society of Pharmacovigilance Amplifies Coordinate... | 20 MAR, 2024, 08:44 ET | 20 MAR, 2024, 08:44 ET American Society of Pharmacovigilance Amplifies Coordinate... | Almost one million Americans have died of adverse drug events, many avoidable, in... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/antengene-initiates-phase-ii-dose-expans... | 20 MAR, 2024, 08:30 ET Antengene Initiates Phase II Dose Expansion Study of Claud... | Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, ... | 20 MAR, 2024, 08:30 ET | 20 MAR, 2024, 08:30 ET Antengene Initiates Phase II Dose Expansion Study of Claud... | Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, ... | 20 MAR, 2024, 08:30 ET Antengene Initiates Phase II Dose Expansion Study of Claud... | 20 MAR, 2024, 08:30 ET | 20 MAR, 2024, 08:30 ET Antengene Initiates Phase II Dose Expansion Study of Claud... | Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, ... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/antengene-publishes-preclinical-paper-on... | 19 MAR, 2024, 20:30 ET Antengene Publishes Preclinical Paper on PD-L1/4-1BB Bispe... | Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, ... | 19 MAR, 2024, 20:30 ET | 19 MAR, 2024, 20:30 ET Antengene Publishes Preclinical Paper on PD-L1/4-1BB Bispe... | Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, ... | 19 MAR, 2024, 20:30 ET Antengene Publishes Preclinical Paper on PD-L1/4-1BB Bispe... | 19 MAR, 2024, 20:30 ET | 19 MAR, 2024, 20:30 ET Antengene Publishes Preclinical Paper on PD-L1/4-1BB Bispe... | Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, ... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/antennova-completes-first-dosing-cohort-... | 20 MAR, 2024, 08:30 ET Antennova Completes First Dosing Cohort for Anti-CD24 mAb,... | Antennova, a clinical-stage biotech company focused on oncology today announced c... | 20 MAR, 2024, 08:30 ET | 20 MAR, 2024, 08:30 ET Antennova Completes First Dosing Cohort for Anti-CD24 mAb,... | Antennova, a clinical-stage biotech company focused on oncology today announced c... | 20 MAR, 2024, 08:30 ET Antennova Completes First Dosing Cohort for Anti-CD24 mAb,... | 20 MAR, 2024, 08:30 ET | 20 MAR, 2024, 08:30 ET Antennova Completes First Dosing Cohort for Anti-CD24 mAb,... | Antennova, a clinical-stage biotech company focused on oncology today announced c... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-fourth-... | 21 MAR, 2024, 16:05 ET Armata Pharmaceuticals Announces Fourth Quarter and Full-Y... | Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a... | 21 MAR, 2024, 16:05 ET | 21 MAR, 2024, 16:05 ET Armata Pharmaceuticals Announces Fourth Quarter and Full-Y... | Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a... | 21 MAR, 2024, 16:05 ET Armata Pharmaceuticals Announces Fourth Quarter and Full-Y... | 21 MAR, 2024, 16:05 ET | 21 MAR, 2024, 16:05 ET Armata Pharmaceuticals Announces Fourth Quarter and Full-Y... | Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/association-for-diagnostics--laboratory-... | 21 MAR, 2024, 08:43 ET Association for Diagnostics & Laboratory Medicine (formerl... | Statement attributable to: Octavia Peck Palmer, PhD President, Association for Di... | 21 MAR, 2024, 08:43 ET | 21 MAR, 2024, 08:43 ET Association for Diagnostics & Laboratory Medicine (formerl... | Statement attributable to: Octavia Peck Palmer, PhD President, Association for Di... | 21 MAR, 2024, 08:43 ET Association for Diagnostics & Laboratory Medicine (formerl... | 21 MAR, 2024, 08:43 ET | 21 MAR, 2024, 08:43 ET Association for Diagnostics & Laboratory Medicine (formerl... | Statement attributable to: Octavia Peck Palmer, PhD President, Association for Di... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/aurora-cannabis-achieves-australias-tga-... | 20 MAR, 2024, 07:15 ET Aurora Cannabis Achieves Australia's TGA GMP Certification... | Milestone Achievement Signals Company's Commitment to Solidifying its Leadership ... | 20 MAR, 2024, 07:15 ET | 20 MAR, 2024, 07:15 ET Aurora Cannabis Achieves Australia's TGA GMP Certification... | Milestone Achievement Signals Company's Commitment to Solidifying its Leadership ... | 20 MAR, 2024, 07:15 ET Aurora Cannabis Achieves Australia's TGA GMP Certification... | 20 MAR, 2024, 07:15 ET | 20 MAR, 2024, 07:15 ET Aurora Cannabis Achieves Australia's TGA GMP Certification... | Milestone Achievement Signals Company's Commitment to Solidifying its Leadership ... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/avidity-biosciences-announces-inducement... | 21 MAR, 2024, 16:05 ET Avidity Biosciences Announces Inducement Grants Under Nasd... | Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to... | 21 MAR, 2024, 16:05 ET | 21 MAR, 2024, 16:05 ET Avidity Biosciences Announces Inducement Grants Under Nasd... | Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to... | 21 MAR, 2024, 16:05 ET Avidity Biosciences Announces Inducement Grants Under Nasd... | 21 MAR, 2024, 16:05 ET | 21 MAR, 2024, 16:05 ET Avidity Biosciences Announces Inducement Grants Under Nasd... | Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/bergenbio-announces-initiation-of-phase-... | 20 MAR, 2024, 14:13 ET BerGenBio Announces Initiation of Phase 2a in First Line N... | BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing... | 20 MAR, 2024, 14:13 ET | 20 MAR, 2024, 14:13 ET BerGenBio Announces Initiation of Phase 2a in First Line N... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | |||||||||||
https://www.prnewswire.com/news-releases/bergenbio-announces-initiation-of-phase-... | 20 MAR, 2024, 14:14 ET BerGenBio Announces Initiation of Phase 2a in First Line N... | BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing... | 20 MAR, 2024, 14:14 ET | 20 MAR, 2024, 14:14 ET BerGenBio Announces Initiation of Phase 2a in First Line N... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | |||||||||||
https://www.prnewswire.com/news-releases/better-cancer-trials-could-be-around-the... | 21 MAR, 2024, 11:00 ET Better cancer trials could be around the corner | Cold Spring Harbor Laboratory Associate Professor and Cancer Center member Tobias... | 21 MAR, 2024, 11:00 ET | 21 MAR, 2024, 11:00 ET Better cancer trials could be around the corner | Cold Spring Harbor Laboratory Associate Professor and Cancer Center member Tobias... | 21 MAR, 2024, 11:00 ET Better cancer trials could be around the corner | 21 MAR, 2024, 11:00 ET | 21 MAR, 2024, 11:00 ET Better cancer trials could be around the corner | Cold Spring Harbor Laboratory Associate Professor and Cancer Center member Tobias... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/bioforum-expands-leadership-team-with-ap... | 19 MAR, 2024, 11:00 ET Bioforum Expands Leadership Team with Appointment of Micha... | Bioforum, the Data Masters, a leading contract research organization (CRO) focuse... | 19 MAR, 2024, 11:00 ET | 19 MAR, 2024, 11:00 ET Bioforum Expands Leadership Team with Appointment of Micha... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | |||||||||||
https://www.prnewswire.com/news-releases/biolinerx-to-report-2023-annual-financia... | 20 MAR, 2024, 07:00 ET BioLineRx to Report 2023 Annual Financial Results on March... | BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical ... | 20 MAR, 2024, 07:00 ET | 20 MAR, 2024, 07:00 ET BioLineRx to Report 2023 Annual Financial Results on March... | BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical ... | 20 MAR, 2024, 07:00 ET BioLineRx to Report 2023 Annual Financial Results on March... | 20 MAR, 2024, 07:00 ET | 20 MAR, 2024, 07:00 ET BioLineRx to Report 2023 Annual Financial Results on March... | BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical ... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/biosion-to-present-three-posters-at-the-... | 21 MAR, 2024, 07:00 ET Biosion to Present Three Posters at the 2024 AACR Meeting | Biosion, a global, clinical-stage biotechnology company, today announced upcoming... | 21 MAR, 2024, 07:00 ET | 21 MAR, 2024, 07:00 ET Biosion to Present Three Posters at the 2024 AACR Meeting | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | |||||||||||
https://www.prnewswire.com/news-releases/blacksmith-medicines-to-present-at-the-g... | 19 MAR, 2024, 10:00 ET Blacksmith Medicines to Present at the Gordon Research Con... | Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discove... | 19 MAR, 2024, 10:00 ET | 19 MAR, 2024, 10:00 ET Blacksmith Medicines to Present at the Gordon Research Con... | Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discove... | 19 MAR, 2024, 10:00 ET Blacksmith Medicines to Present at the Gordon Research Con... | 19 MAR, 2024, 10:00 ET | 19 MAR, 2024, 10:00 ET Blacksmith Medicines to Present at the Gordon Research Con... | Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discove... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/brazilian-entrepreneur-launches-entourag... | 20 MAR, 2024, 08:38 ET Brazilian Entrepreneur Launches Entourage Phytolab on One ... | Entourage Phytolab, under the leadership of Brazilian entrepreneur Caio Abreu, an... | 20 MAR, 2024, 08:38 ET | 20 MAR, 2024, 08:38 ET Brazilian Entrepreneur Launches Entourage Phytolab on One ... | Entourage Phytolab, under the leadership of Brazilian entrepreneur Caio Abreu, an... | 20 MAR, 2024, 08:38 ET Brazilian Entrepreneur Launches Entourage Phytolab on One ... | 20 MAR, 2024, 08:38 ET | 20 MAR, 2024, 08:38 ET Brazilian Entrepreneur Launches Entourage Phytolab on One ... | Entourage Phytolab, under the leadership of Brazilian entrepreneur Caio Abreu, an... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/cell-expansion-market-worth-26-7-billion... | 19 MAR, 2024, 10:30 ET Cell Expansion Market Worth $26.7 billion | MarketsandMark... | Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion... | 19 MAR, 2024, 10:30 ET | 19 MAR, 2024, 10:30 ET Cell Expansion Market Worth $26.7 billion | MarketsandMark... | Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion... | 19 MAR, 2024, 10:30 ET Cell Expansion Market Worth $26.7 billion | MarketsandMark... | 19 MAR, 2024, 10:30 ET | 19 MAR, 2024, 10:30 ET Cell Expansion Market Worth $26.7 billion | MarketsandMark... | Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/childrens-minnesota-hospital-board-of-di... | 19 MAR, 2024, 10:00 ET Children's Minnesota Hospital Board of Directors adds new ... | Children's Minnesota announced today the appointment of Matt Van Slooten to its h... | 19 MAR, 2024, 10:00 ET | 19 MAR, 2024, 10:00 ET Children's Minnesota Hospital Board of Directors adds new ... | Children's Minnesota announced today the appointment of Matt Van Slooten to its h... | 19 MAR, 2024, 10:00 ET Children's Minnesota Hospital Board of Directors adds new ... | 19 MAR, 2024, 10:00 ET | 19 MAR, 2024, 10:00 ET Children's Minnesota Hospital Board of Directors adds new ... | Children's Minnesota announced today the appointment of Matt Van Slooten to its h... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/china-jo-jo-drugstores-regains-complianc... | 19 MAR, 2024, 16:05 ET China Jo-Jo Drugstores Regains Compliance with Nasdaq Mini... | China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company")... | 19 MAR, 2024, 16:05 ET | 19 MAR, 2024, 16:05 ET China Jo-Jo Drugstores Regains Compliance with Nasdaq Mini... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | |||||||||||
https://www.prnewswire.com/news-releases/cognizant-applique-lia-generative-pour-a... | 19 MAR, 2024, 21:12 ET Cognizant applique l'IA générative pour améliorer la décou... | 19 MAR, 2024, 21:12 ET | Cognizant applique l'IA générative pour améliorer la découverte de médicaments po... | 19 MAR, 2024, 21:12 ET Cognizant applique l'IA générative pour améliorer la décou... | 19 MAR, 2024, 21:12 ET Cognizant applique l'IA générative pour améliorer la décou... | 19 MAR, 2024, 21:12 ET | 19 MAR, 2024, 21:12 ET Cognizant applique l'IA générative pour améliorer la décou... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||||
https://www.prnewswire.com/news-releases/cognizant-setzt-generative-ki-ein-um-mit... | 19 MAR, 2024, 17:45 ET Cognizant setzt generative KI ein, um mit NVIDIA BioNeMo d... | 19 MAR, 2024, 17:45 ET | Cognizant setzt generative KI ein, um mit NVIDIA BioNeMo die Arzneimittelforschun... | 19 MAR, 2024, 17:45 ET Cognizant setzt generative KI ein, um mit NVIDIA BioNeMo d... | 19 MAR, 2024, 17:45 ET Cognizant setzt generative KI ein, um mit NVIDIA BioNeMo d... | 19 MAR, 2024, 17:45 ET | 19 MAR, 2024, 17:45 ET Cognizant setzt generative KI ein, um mit NVIDIA BioNeMo d... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||||
https://www.prnewswire.com/news-releases/cognizant-vyuije-generativnu-ai-na-zlepe... | 19 MAR, 2024, 14:05 ET Cognizant využije generatívnu AI na zlepšenie vývinu lieko... | 19 MAR, 2024, 14:05 ET | Cognizant využije generatívnu AI na zlepšenie vývinu liekov pre farmaceutických k... | 19 MAR, 2024, 14:05 ET Cognizant využije generatívnu AI na zlepšenie vývinu lieko... | 19 MAR, 2024, 14:05 ET Cognizant využije generatívnu AI na zlepšenie vývinu lieko... | 19 MAR, 2024, 14:05 ET | 19 MAR, 2024, 14:05 ET Cognizant využije generatívnu AI na zlepšenie vývinu lieko... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||||
https://www.prnewswire.com/news-releases/community-pharmacies-back-in-business-af... | 20 MAR, 2024, 05:00 ET Community Pharmacies Back In Business After Distributor Cu... | You own a small community pharmacy. One day the phone rings and your pharmaceutic... | 20 MAR, 2024, 05:00 ET | 20 MAR, 2024, 05:00 ET Community Pharmacies Back In Business After Distributor Cu... | You own a small community pharmacy. One day the phone rings and your pharmaceutic... | 20 MAR, 2024, 05:00 ET Community Pharmacies Back In Business After Distributor Cu... | 20 MAR, 2024, 05:00 ET | 20 MAR, 2024, 05:00 ET Community Pharmacies Back In Business After Distributor Cu... | You own a small community pharmacy. One day the phone rings and your pharmaceutic... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/corealis-pharma-completes-laboratory-exp... | 20 MAR, 2024, 15:42 ET Corealis Pharma Completes Laboratory Expansion | Corealis Pharma Inc. is pleased to announce that the expansion project of its sta... | 20 MAR, 2024, 15:42 ET | 20 MAR, 2024, 15:42 ET Corealis Pharma Completes Laboratory Expansion | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | |||||||||||
https://www.prnewswire.com/news-releases/dna-sequencing-market-projected-to-reach... | 21 MAR, 2024, 21:03 ET DNA Sequencing Market Projected to Reach $210.34 billion b... | The report titled "DNA Sequencing Market by Product & Services (Consumables, Inst... | 21 MAR, 2024, 21:03 ET | 21 MAR, 2024, 21:03 ET DNA Sequencing Market Projected to Reach $210.34 billion b... | The report titled "DNA Sequencing Market by Product & Services (Consumables, Inst... | 21 MAR, 2024, 21:03 ET DNA Sequencing Market Projected to Reach $210.34 billion b... | 21 MAR, 2024, 21:03 ET | 21 MAR, 2024, 21:03 ET DNA Sequencing Market Projected to Reach $210.34 billion b... | The report titled "DNA Sequencing Market by Product & Services (Consumables, Inst... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/durect-corporation-to-announce-fourth-qu... | 20 MAR, 2024, 16:30 ET DURECT Corporation to Announce Fourth Quarter and Full Yea... | DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneer... | 20 MAR, 2024, 16:30 ET | 20 MAR, 2024, 16:30 ET DURECT Corporation to Announce Fourth Quarter and Full Yea... | DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneer... | 20 MAR, 2024, 16:30 ET DURECT Corporation to Announce Fourth Quarter and Full Yea... | 20 MAR, 2024, 16:30 ET | 20 MAR, 2024, 16:30 ET DURECT Corporation to Announce Fourth Quarter and Full Yea... | DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneer... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/endo-announces-confirmation-of-plan-of-r... | 19 MAR, 2024, 17:30 ET Endo Announces Confirmation of Plan of Reorganization | Endo International plc (OTC: ENDPQ) ("Endo" or the "Company") today announced tha... | 19 MAR, 2024, 17:30 ET | 19 MAR, 2024, 17:30 ET Endo Announces Confirmation of Plan of Reorganization | Endo International plc (OTC: ENDPQ) ("Endo" or the "Company") today announced tha... | 19 MAR, 2024, 17:30 ET Endo Announces Confirmation of Plan of Reorganization | 19 MAR, 2024, 17:30 ET | 19 MAR, 2024, 17:30 ET Endo Announces Confirmation of Plan of Reorganization | Endo International plc (OTC: ENDPQ) ("Endo" or the "Company") today announced tha... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/europe-laboratory-developed-tests-market... | 19 MAR, 2024, 10:45 ET Europe Laboratory Developed Tests Market Analysis Report 2... | The "Europe Laboratory Developed Tests Market Size, Share & Trends Analysis Repor... | 19 MAR, 2024, 10:45 ET | 19 MAR, 2024, 10:45 ET Europe Laboratory Developed Tests Market Analysis Report 2... | The "Europe Laboratory Developed Tests Market Size, Share & Trends Analysis Repor... | 19 MAR, 2024, 10:45 ET Europe Laboratory Developed Tests Market Analysis Report 2... | 19 MAR, 2024, 10:45 ET | 19 MAR, 2024, 10:45 ET Europe Laboratory Developed Tests Market Analysis Report 2... | The "Europe Laboratory Developed Tests Market Size, Share & Trends Analysis Repor... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/everest-medicines-announces-singapore-he... | 19 MAR, 2024, 21:03 ET Everest Medicines Announces Singapore Health Sciences Auth... | Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutica... | 19 MAR, 2024, 21:03 ET | 19 MAR, 2024, 21:03 ET Everest Medicines Announces Singapore Health Sciences Auth... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | |||||||||||
https://www.prnewswire.com/news-releases/fda-approves-nonsteroidal-treatment-for-... | 21 MAR, 2024, 19:35 ET FDA Approves Nonsteroidal Treatment for Duchenne Muscular ... | Today, the U.S. Food and Drug Administration approved Duvyzat (givinostat) oral m... | 21 MAR, 2024, 19:35 ET | 21 MAR, 2024, 19:35 ET FDA Approves Nonsteroidal Treatment for Duchenne Muscular ... | Today, the U.S. Food and Drug Administration approved Duvyzat (givinostat) oral m... | 21 MAR, 2024, 19:35 ET FDA Approves Nonsteroidal Treatment for Duchenne Muscular ... | 21 MAR, 2024, 19:35 ET | 21 MAR, 2024, 19:35 ET FDA Approves Nonsteroidal Treatment for Duchenne Muscular ... | Today, the U.S. Food and Drug Administration approved Duvyzat (givinostat) oral m... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/fda-grants-orphan-drug-designation-to-ce... | 21 MAR, 2024, 08:00 ET FDA Grants Orphan Drug Designation to Cevidoplenib for ITP... | Oscotec Inc. has secured orphan drug designation (ODD) from the U.S. Food and Dru... | 21 MAR, 2024, 08:00 ET | 21 MAR, 2024, 08:00 ET FDA Grants Orphan Drug Designation to Cevidoplenib for ITP... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | |||||||||||
https://www.prnewswire.com/news-releases/fda-roundup-march-19-2024-302093555.html... | 19 MAR, 2024, 16:07 ET FDA Roundup: March 19, 2024 | Today, the U.S. Food and Drug Administration is providing an at-a-glance summary ... | 19 MAR, 2024, 16:07 ET | 19 MAR, 2024, 16:07 ET FDA Roundup: March 19, 2024 | Today, the U.S. Food and Drug Administration is providing an at-a-glance summary ... | 19 MAR, 2024, 16:07 ET FDA Roundup: March 19, 2024 | 19 MAR, 2024, 16:07 ET | 19 MAR, 2024, 16:07 ET FDA Roundup: March 19, 2024 | Today, the U.S. Food and Drug Administration is providing an at-a-glance summary ... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/flamingo-therapeutics-appoints-leading-m... | 21 MAR, 2024, 07:00 ET Flamingo Therapeutics Appoints Leading Medical Oncologist ... | Flamingo Therapeutics ("Flamingo") today announced the appointment of Ezra Cohen,... | 21 MAR, 2024, 07:00 ET | 21 MAR, 2024, 07:00 ET Flamingo Therapeutics Appoints Leading Medical Oncologist ... | Flamingo Therapeutics ("Flamingo") today announced the appointment of Ezra Cohen,... | 21 MAR, 2024, 07:00 ET Flamingo Therapeutics Appoints Leading Medical Oncologist ... | 21 MAR, 2024, 07:00 ET | 21 MAR, 2024, 07:00 ET Flamingo Therapeutics Appoints Leading Medical Oncologist ... | Flamingo Therapeutics ("Flamingo") today announced the appointment of Ezra Cohen,... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/fusion-pharmaceuticals-reports-fourth-qu... | 20 MAR, 2024, 16:05 ET Fusion Pharmaceuticals Reports Fourth Quarter and Full Yea... | Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company foc... | 20 MAR, 2024, 16:05 ET | 20 MAR, 2024, 16:05 ET Fusion Pharmaceuticals Reports Fourth Quarter and Full Yea... | Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company foc... | 20 MAR, 2024, 16:05 ET Fusion Pharmaceuticals Reports Fourth Quarter and Full Yea... | 20 MAR, 2024, 16:05 ET | 20 MAR, 2024, 16:05 ET Fusion Pharmaceuticals Reports Fourth Quarter and Full Yea... | Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company foc... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/gastroenterology-group-of-naples-introdu... | 19 MAR, 2024, 10:11 ET Gastroenterology Group of Naples Introduces Innovative Axo... | Gastroenterology Group of Naples, a partner practice of United Digestive, is plea... | 19 MAR, 2024, 10:11 ET | 19 MAR, 2024, 10:11 ET Gastroenterology Group of Naples Introduces Innovative Axo... | Gastroenterology Group of Naples, a partner practice of United Digestive, is plea... | 19 MAR, 2024, 10:11 ET Gastroenterology Group of Naples Introduces Innovative Axo... | 19 MAR, 2024, 10:11 ET | 19 MAR, 2024, 10:11 ET Gastroenterology Group of Naples Introduces Innovative Axo... | Gastroenterology Group of Naples, a partner practice of United Digestive, is plea... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/global-hematological-drugs-market-foreca... | 19 MAR, 2024, 23:15 ET Global Hematological Drugs Market Forecast: Significant Gr... | The "Global Hematological Drugs Market (2023-2028) Competitive Analysis, Impact o... | 19 MAR, 2024, 23:15 ET | 19 MAR, 2024, 23:15 ET Global Hematological Drugs Market Forecast: Significant Gr... | The "Global Hematological Drugs Market (2023-2028) Competitive Analysis, Impact o... | 19 MAR, 2024, 23:15 ET Global Hematological Drugs Market Forecast: Significant Gr... | 19 MAR, 2024, 23:15 ET | 19 MAR, 2024, 23:15 ET Global Hematological Drugs Market Forecast: Significant Gr... | The "Global Hematological Drugs Market (2023-2028) Competitive Analysis, Impact o... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/global-menopause-market-analysis-report-... | 20 MAR, 2024, 18:30 ET Global Menopause Market Analysis Report 2024, Featuring Pr... | The "Global Menopause Market Size, Share & Trends Analysis Report by Treatment (D... | 20 MAR, 2024, 18:30 ET | 20 MAR, 2024, 18:30 ET Global Menopause Market Analysis Report 2024, Featuring Pr... | The "Global Menopause Market Size, Share & Trends Analysis Report by Treatment (D... | 20 MAR, 2024, 18:30 ET Global Menopause Market Analysis Report 2024, Featuring Pr... | 20 MAR, 2024, 18:30 ET | 20 MAR, 2024, 18:30 ET Global Menopause Market Analysis Report 2024, Featuring Pr... | The "Global Menopause Market Size, Share & Trends Analysis Report by Treatment (D... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/global-ophthalmic-devices-diagnostics-an... | 21 MAR, 2024, 05:50 ET Global Ophthalmic Devices, Diagnostics, and Surgical Equip... | Ophthalmic Devices, Diagnostics, and Surgical Equipment drive global vision care,... | 21 MAR, 2024, 05:50 ET | 21 MAR, 2024, 05:50 ET Global Ophthalmic Devices, Diagnostics, and Surgical Equip... | Ophthalmic Devices, Diagnostics, and Surgical Equipment drive global vision care,... | 21 MAR, 2024, 05:50 ET Global Ophthalmic Devices, Diagnostics, and Surgical Equip... | 21 MAR, 2024, 05:50 ET | 21 MAR, 2024, 05:50 ET Global Ophthalmic Devices, Diagnostics, and Surgical Equip... | Ophthalmic Devices, Diagnostics, and Surgical Equipment drive global vision care,... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/global-otc-artificial-tears-analysis-rep... | 21 MAR, 2024, 19:45 ET Global OTC Artificial Tears Analysis Report 2023-2030: The... | The "OTC Artificial Tears Market, Size, Global Forecast 2024-2030, Industry Trend... | 21 MAR, 2024, 19:45 ET | 21 MAR, 2024, 19:45 ET Global OTC Artificial Tears Analysis Report 2023-2030: The... | The "OTC Artificial Tears Market, Size, Global Forecast 2024-2030, Industry Trend... | 21 MAR, 2024, 19:45 ET Global OTC Artificial Tears Analysis Report 2023-2030: The... | 21 MAR, 2024, 19:45 ET | 21 MAR, 2024, 19:45 ET Global OTC Artificial Tears Analysis Report 2023-2030: The... | The "OTC Artificial Tears Market, Size, Global Forecast 2024-2030, Industry Trend... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/global-subcutaneous-immunoglobulin-marke... | 21 MAR, 2024, 19:00 ET Global Subcutaneous Immunoglobulin Market Analysis & Forec... | The "Global Subcutaneous Immunoglobulin Market Analysis & Forecast to 2024-2034: ... | 21 MAR, 2024, 19:00 ET | 21 MAR, 2024, 19:00 ET Global Subcutaneous Immunoglobulin Market Analysis & Forec... | The "Global Subcutaneous Immunoglobulin Market Analysis & Forecast to 2024-2034: ... | 21 MAR, 2024, 19:00 ET Global Subcutaneous Immunoglobulin Market Analysis & Forec... | 21 MAR, 2024, 19:00 ET | 21 MAR, 2024, 19:00 ET Global Subcutaneous Immunoglobulin Market Analysis & Forec... | The "Global Subcutaneous Immunoglobulin Market Analysis & Forecast to 2024-2034: ... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/global-transfection-technologies-market-... | 21 MAR, 2024, 13:30 ET Global Transfection Technologies Market Forecast Report to... | The "Global Transfection Technologies Market by Product (Kits, Equipment), Method... | 21 MAR, 2024, 13:30 ET | 21 MAR, 2024, 13:30 ET Global Transfection Technologies Market Forecast Report to... | The "Global Transfection Technologies Market by Product (Kits, Equipment), Method... | 21 MAR, 2024, 13:30 ET Global Transfection Technologies Market Forecast Report to... | 21 MAR, 2024, 13:30 ET | 21 MAR, 2024, 13:30 ET Global Transfection Technologies Market Forecast Report to... | The "Global Transfection Technologies Market by Product (Kits, Equipment), Method... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/good-for-business-ptcb-launches-series-h... | 19 MAR, 2024, 09:00 ET Good for Business: PTCB Launches Series Highlighting Emplo... | The Pharmacy Technician Certification Board (PTCB) has launched a new series prof... | 19 MAR, 2024, 09:00 ET | 19 MAR, 2024, 09:00 ET Good for Business: PTCB Launches Series Highlighting Emplo... | The Pharmacy Technician Certification Board (PTCB) has launched a new series prof... | 19 MAR, 2024, 09:00 ET Good for Business: PTCB Launches Series Highlighting Emplo... | 19 MAR, 2024, 09:00 ET | 19 MAR, 2024, 09:00 ET Good for Business: PTCB Launches Series Highlighting Emplo... | The Pharmacy Technician Certification Board (PTCB) has launched a new series prof... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/hanall-biopharma-reports-full-year-2023-... | 21 MAR, 2024, 07:00 ET HanAll Biopharma Reports Full-Year 2023 Financial Results ... | HanAll Biopharma Co., Ltd. (KRX: 009420.KS), a global biopharmaceutical company c... | 21 MAR, 2024, 07:00 ET | 21 MAR, 2024, 07:00 ET HanAll Biopharma Reports Full-Year 2023 Financial Results ... | HanAll Biopharma Co., Ltd. (KRX: 009420.KS), a global biopharmaceutical company c... | 21 MAR, 2024, 07:00 ET HanAll Biopharma Reports Full-Year 2023 Financial Results ... | 21 MAR, 2024, 07:00 ET | 21 MAR, 2024, 07:00 ET HanAll Biopharma Reports Full-Year 2023 Financial Results ... | HanAll Biopharma Co., Ltd. (KRX: 009420.KS), a global biopharmaceutical company c... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/healthme-and-galenusrx-forge-strategic-p... | 20 MAR, 2024, 08:22 ET healthŌme and GalenusRx Forge Strategic Partnership to Lau... | healthŌme®, Inc., a leading genomics-based, precision health management company s... | 20 MAR, 2024, 08:22 ET | 20 MAR, 2024, 08:22 ET healthŌme and GalenusRx Forge Strategic Partnership to Lau... | healthŌme®, Inc., a leading genomics-based, precision health management company s... | 20 MAR, 2024, 08:22 ET healthŌme and GalenusRx Forge Strategic Partnership to Lau... | 20 MAR, 2024, 08:22 ET | 20 MAR, 2024, 08:22 ET healthŌme and GalenusRx Forge Strategic Partnership to Lau... | healthŌme®, Inc., a leading genomics-based, precision health management company s... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/henlius-2023-annual-results-revenue-surp... | 21 MAR, 2024, 07:53 ET Henlius 2023 Annual Results: Revenue surpassed RMB5.39 bil... | Henlius (2696.HK) announced its 2023 annual results. During the reporting period,... | 21 MAR, 2024, 07:53 ET | 21 MAR, 2024, 07:53 ET Henlius 2023 Annual Results: Revenue surpassed RMB5.39 bil... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | |||||||||||
https://www.prnewswire.com/news-releases/hi-bio-receives-fda-orphan-drug-designat... | 21 MAR, 2024, 08:00 ET HI-Bio Receives FDA Orphan Drug Designation for Felzartama... | Human Immunology Biosciences (HI-Bio™), a clinical-stage biotechnology company de... | 21 MAR, 2024, 08:00 ET | 21 MAR, 2024, 08:00 ET HI-Bio Receives FDA Orphan Drug Designation for Felzartama... | Human Immunology Biosciences (HI-Bio™), a clinical-stage biotechnology company de... | 21 MAR, 2024, 08:00 ET HI-Bio Receives FDA Orphan Drug Designation for Felzartama... | 21 MAR, 2024, 08:00 ET | 21 MAR, 2024, 08:00 ET HI-Bio Receives FDA Orphan Drug Designation for Felzartama... | Human Immunology Biosciences (HI-Bio™), a clinical-stage biotechnology company de... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/im-cannabis-to-report-fourth-quarter-and... | 20 MAR, 2024, 07:00 ET IM Cannabis to Report Fourth Quarter and Full Year 2023 Fi... | IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IM... | 20 MAR, 2024, 07:00 ET | 20 MAR, 2024, 07:00 ET IM Cannabis to Report Fourth Quarter and Full Year 2023 Fi... | IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IM... | 20 MAR, 2024, 07:00 ET IM Cannabis to Report Fourth Quarter and Full Year 2023 Fi... | 20 MAR, 2024, 07:00 ET | 20 MAR, 2024, 07:00 ET IM Cannabis to Report Fourth Quarter and Full Year 2023 Fi... | IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IM... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/immunic-receives-notice-of-allowance-for... | 20 MAR, 2024, 06:30 ET Immunic Receives Notice of Allowance for Composition-of-Ma... | Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipel... | 20 MAR, 2024, 06:30 ET | 20 MAR, 2024, 06:30 ET Immunic Receives Notice of Allowance for Composition-of-Ma... | Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipel... | 20 MAR, 2024, 06:30 ET Immunic Receives Notice of Allowance for Composition-of-Ma... | 20 MAR, 2024, 06:30 ET | 20 MAR, 2024, 06:30 ET Immunic Receives Notice of Allowance for Composition-of-Ma... | Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipel... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/immuno-oncology-therapies-in-depth-analy... | 20 MAR, 2024, 21:45 ET Immuno-Oncology Therapies: In-Depth Analysis of the Rapidl... | The "Innovation Waves in Immuno-oncology Therapy Development" report has been add... | 20 MAR, 2024, 21:45 ET | 20 MAR, 2024, 21:45 ET Immuno-Oncology Therapies: In-Depth Analysis of the Rapidl... | The "Innovation Waves in Immuno-oncology Therapy Development" report has been add... | 20 MAR, 2024, 21:45 ET Immuno-Oncology Therapies: In-Depth Analysis of the Rapidl... | 20 MAR, 2024, 21:45 ET | 20 MAR, 2024, 21:45 ET Immuno-Oncology Therapies: In-Depth Analysis of the Rapidl... | The "Innovation Waves in Immuno-oncology Therapy Development" report has been add... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/innovent-announces-2023-annual-results-a... | 20 MAR, 2024, 07:41 ET Innovent Announces 2023 Annual Results and Business Update... | Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutica... | 20 MAR, 2024, 07:41 ET | 20 MAR, 2024, 07:41 ET Innovent Announces 2023 Annual Results and Business Update... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | |||||||||||
https://www.prnewswire.com/news-releases/iron-drugs-market-size-to-grow-by-usd-3-... | 21 MAR, 2024, 22:24 ET Iron Drugs Market size to grow by USD 3.55 billion from 20... | The iron drugs market is set to experience substantial growth between 2023 and 20... | 21 MAR, 2024, 22:24 ET | 21 MAR, 2024, 22:24 ET Iron Drugs Market size to grow by USD 3.55 billion from 20... | The iron drugs market is set to experience substantial growth between 2023 and 20... | 21 MAR, 2024, 22:24 ET Iron Drugs Market size to grow by USD 3.55 billion from 20... | 21 MAR, 2024, 22:24 ET | 21 MAR, 2024, 22:24 ET Iron Drugs Market size to grow by USD 3.55 billion from 20... | The iron drugs market is set to experience substantial growth between 2023 and 20... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/jco-precision-oncology-jco-po-publishes-... | 21 MAR, 2024, 16:00 ET JCO® Precision Oncology (JCO PO) Publishes Study Demonstra... | OncoHost, a technology company transforming the approach to precision medicine fo... | 21 MAR, 2024, 16:00 ET | 21 MAR, 2024, 16:00 ET JCO® Precision Oncology (JCO PO) Publishes Study Demonstra... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | |||||||||||
https://www.prnewswire.com/news-releases/labcorp-launches-ptau217-blood-biomarker... | 20 MAR, 2024, 07:00 ET Labcorp Launches pTau217 Blood Biomarker Test to Accelerat... | Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory se... | 20 MAR, 2024, 07:00 ET | 20 MAR, 2024, 07:00 ET Labcorp Launches pTau217 Blood Biomarker Test to Accelerat... | Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory se... | 20 MAR, 2024, 07:00 ET Labcorp Launches pTau217 Blood Biomarker Test to Accelerat... | 20 MAR, 2024, 07:00 ET | 20 MAR, 2024, 07:00 ET Labcorp Launches pTau217 Blood Biomarker Test to Accelerat... | Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory se... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/m8-pharmaceuticals-an-acino-company-sign... | 20 MAR, 2024, 10:00 ET M8 Pharmaceuticals, an Acino company, signs an exclusive a... | M8 Pharmaceuticals, an Acino company ("M8") and SERB Pharmaceuticals ("SERB"), a ... | 20 MAR, 2024, 10:00 ET | 20 MAR, 2024, 10:00 ET M8 Pharmaceuticals, an Acino company, signs an exclusive a... | M8 Pharmaceuticals, an Acino company ("M8") and SERB Pharmaceuticals ("SERB"), a ... | 20 MAR, 2024, 10:00 ET M8 Pharmaceuticals, an Acino company, signs an exclusive a... | 20 MAR, 2024, 10:00 ET | 20 MAR, 2024, 10:00 ET M8 Pharmaceuticals, an Acino company, signs an exclusive a... | M8 Pharmaceuticals, an Acino company ("M8") and SERB Pharmaceuticals ("SERB"), a ... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/mabwell-presented-iddc-platform-technolo... | 21 MAR, 2024, 02:11 ET Mabwell Presented IDDC™ Platform Technology and ADC Drug D... | Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire i... | 21 MAR, 2024, 02:11 ET | 21 MAR, 2024, 02:11 ET Mabwell Presented IDDC™ Platform Technology and ADC Drug D... | Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire i... | 21 MAR, 2024, 02:11 ET Mabwell Presented IDDC™ Platform Technology and ADC Drug D... | 21 MAR, 2024, 02:11 ET | 21 MAR, 2024, 02:11 ET Mabwell Presented IDDC™ Platform Technology and ADC Drug D... | Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire i... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/manufacturing-execution-system-in-life-s... | 19 MAR, 2024, 18:15 ET Manufacturing Execution System in Life Sciences Market Rep... | The "Manufacturing Execution System in Life Sciences Market Size, Share & Trends ... | 19 MAR, 2024, 18:15 ET | 19 MAR, 2024, 18:15 ET Manufacturing Execution System in Life Sciences Market Rep... | The "Manufacturing Execution System in Life Sciences Market Size, Share & Trends ... | 19 MAR, 2024, 18:15 ET Manufacturing Execution System in Life Sciences Market Rep... | 19 MAR, 2024, 18:15 ET | 19 MAR, 2024, 18:15 ET Manufacturing Execution System in Life Sciences Market Rep... | The "Manufacturing Execution System in Life Sciences Market Size, Share & Trends ... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/medical-device-contract-manufacturing-ma... | 20 MAR, 2024, 10:30 ET Medical Device Contract Manufacturing Market Worth $149.4 ... | Medical Device Contract Manufacturing Market in terms of revenue was estimated to... | 20 MAR, 2024, 10:30 ET | 20 MAR, 2024, 10:30 ET Medical Device Contract Manufacturing Market Worth $149.4 ... | Medical Device Contract Manufacturing Market in terms of revenue was estimated to... | 20 MAR, 2024, 10:30 ET Medical Device Contract Manufacturing Market Worth $149.4 ... | 20 MAR, 2024, 10:30 ET | 20 MAR, 2024, 10:30 ET Medical Device Contract Manufacturing Market Worth $149.4 ... | Medical Device Contract Manufacturing Market in terms of revenue was estimated to... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/methotrexate-drug-demand-soaring-due-to-... | 19 MAR, 2024, 10:15 ET Methotrexate Drug Demand Soaring Due to Chronic Disease Bu... | Future Market Insights anticipates the methotrexate drug market to reach US$621.3... | 19 MAR, 2024, 10:15 ET | 19 MAR, 2024, 10:15 ET Methotrexate Drug Demand Soaring Due to Chronic Disease Bu... | Future Market Insights anticipates the methotrexate drug market to reach US$621.3... | 19 MAR, 2024, 10:15 ET Methotrexate Drug Demand Soaring Due to Chronic Disease Bu... | 19 MAR, 2024, 10:15 ET | 19 MAR, 2024, 10:15 ET Methotrexate Drug Demand Soaring Due to Chronic Disease Bu... | Future Market Insights anticipates the methotrexate drug market to reach US$621.3... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/mike-grey-appointed-executive-chair-of-t... | 21 MAR, 2024, 06:30 ET Mike Grey appointed Executive Chair of Theolytics' Board o... | Theolytics, a biotechnology company developing category changing cancer therapies... | 21 MAR, 2024, 06:30 ET | 21 MAR, 2024, 06:30 ET Mike Grey appointed Executive Chair of Theolytics' Board o... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | |||||||||||
https://www.prnewswire.com/news-releases/mira-pharmaceuticals-welcomes-dr-itzchak... | 21 MAR, 2024, 11:04 ET MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former He... | MIRA Pharmaceuticals Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), an innovative... | 21 MAR, 2024, 11:04 ET | 21 MAR, 2024, 11:04 ET MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former He... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | |||||||||||
https://www.prnewswire.com/news-releases/moasc-presents-cary-presant-md-young-inv... | 19 MAR, 2024, 11:14 ET MOASC Presents Cary Presant, MD Young Investigator Award | The Medical Oncology Association of Southern California, Inc. (MOASC), a Californ... | 19 MAR, 2024, 11:14 ET | 19 MAR, 2024, 11:14 ET MOASC Presents Cary Presant, MD Young Investigator Award | The Medical Oncology Association of Southern California, Inc. (MOASC), a Californ... | 19 MAR, 2024, 11:14 ET MOASC Presents Cary Presant, MD Young Investigator Award | 19 MAR, 2024, 11:14 ET | 19 MAR, 2024, 11:14 ET MOASC Presents Cary Presant, MD Young Investigator Award | The Medical Oncology Association of Southern California, Inc. (MOASC), a Californ... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/model-medicines-discovers-new-pan-antivi... | 20 MAR, 2024, 08:00 ET Model Medicines Discovers New Pan-Antiviral Chemical Entit... | Model Medicines, a leading human health company specializing in generative AI-dri... | 20 MAR, 2024, 08:00 ET | 20 MAR, 2024, 08:00 ET Model Medicines Discovers New Pan-Antiviral Chemical Entit... | Model Medicines, a leading human health company specializing in generative AI-dri... | 20 MAR, 2024, 08:00 ET Model Medicines Discovers New Pan-Antiviral Chemical Entit... | 20 MAR, 2024, 08:00 ET | 20 MAR, 2024, 08:00 ET Model Medicines Discovers New Pan-Antiviral Chemical Entit... | Model Medicines, a leading human health company specializing in generative AI-dri... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/molecular-robotics-market-share-analysis... | 21 MAR, 2024, 12:45 ET Molecular Robotics Market Share Analysis, Industry Trends ... | The "Molecular Robotics - Market Share Analysis, Industry Trends & Statistics, Gr... | 21 MAR, 2024, 12:45 ET | 21 MAR, 2024, 12:45 ET Molecular Robotics Market Share Analysis, Industry Trends ... | The "Molecular Robotics - Market Share Analysis, Industry Trends & Statistics, Gr... | 21 MAR, 2024, 12:45 ET Molecular Robotics Market Share Analysis, Industry Trends ... | 21 MAR, 2024, 12:45 ET | 21 MAR, 2024, 12:45 ET Molecular Robotics Market Share Analysis, Industry Trends ... | The "Molecular Robotics - Market Share Analysis, Industry Trends & Statistics, Gr... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/moleculin-to-report-full-year-2023-finan... | 20 MAR, 2024, 07:30 ET Moleculin to Report Full Year 2023 Financial Results on Ma... | Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinica... | 20 MAR, 2024, 07:30 ET | 20 MAR, 2024, 07:30 ET Moleculin to Report Full Year 2023 Financial Results on Ma... | Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinica... | 20 MAR, 2024, 07:30 ET Moleculin to Report Full Year 2023 Financial Results on Ma... | 20 MAR, 2024, 07:30 ET | 20 MAR, 2024, 07:30 ET Moleculin to Report Full Year 2023 Financial Results on Ma... | Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinica... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/neuroderm----nd0612---boundless--3020935... | 19 MAR, 2024, 15:16 ET NeuroDerm: результаты исследования терапии ND0612 при Парк... | 19 MAR, 2024, 15:16 ET | NeuroDerm: результаты исследования терапии ND0612 при Паркинсоне (BouNDless) поло... | 19 MAR, 2024, 15:16 ET NeuroDerm: результаты исследования терапии ND0612 при Парк... | 19 MAR, 2024, 15:16 ET NeuroDerm: результаты исследования терапии ND0612 при Парк... | 19 MAR, 2024, 15:16 ET | 19 MAR, 2024, 15:16 ET NeuroDerm: результаты исследования терапии ND0612 при Парк... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||||
https://www.prnewswire.com/news-releases/neuroderm-annonce-la-publication-des-res... | 19 MAR, 2024, 20:46 ET NeuroDerm annonce la publication des résultats positifs de... | 19 MAR, 2024, 20:46 ET | NeuroDerm annonce la publication des résultats positifs de l'essai BouNDless de p... | 19 MAR, 2024, 20:46 ET NeuroDerm annonce la publication des résultats positifs de... | 19 MAR, 2024, 20:46 ET NeuroDerm annonce la publication des résultats positifs de... | 19 MAR, 2024, 20:46 ET | 19 MAR, 2024, 20:46 ET NeuroDerm annonce la publication des résultats positifs de... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||||
https://www.prnewswire.com/news-releases/neuroderm-gibt-die-veroffentlichung-posi... | 19 MAR, 2024, 22:52 ET NeuroDerm gibt die Veröffentlichung positiver Ergebnisse d... | 19 MAR, 2024, 22:52 ET | NeuroDerm gibt die Veröffentlichung positiver Ergebnisse der Phase-3-Studie BouND... | 19 MAR, 2024, 22:52 ET NeuroDerm gibt die Veröffentlichung positiver Ergebnisse d... | 19 MAR, 2024, 22:52 ET NeuroDerm gibt die Veröffentlichung positiver Ergebnisse d... | 19 MAR, 2024, 22:52 ET | 19 MAR, 2024, 22:52 ET NeuroDerm gibt die Veröffentlichung positiver Ergebnisse d... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||||
https://www.prnewswire.com/news-releases/neuroderm-oznamuje-zverejnenie-pozitivny... | 19 MAR, 2024, 15:04 ET NeuroDerm oznamuje zverejnenie pozitívnych výsledkov z 3. ... | 19 MAR, 2024, 15:04 ET | NeuroDerm oznamuje zverejnenie pozitívnych výsledkov z 3. fázy 3 štúdie BouNDless... | 19 MAR, 2024, 15:04 ET NeuroDerm oznamuje zverejnenie pozitívnych výsledkov z 3. ... | 19 MAR, 2024, 15:04 ET NeuroDerm oznamuje zverejnenie pozitívnych výsledkov z 3. ... | 19 MAR, 2024, 15:04 ET | 19 MAR, 2024, 15:04 ET NeuroDerm oznamuje zverejnenie pozitívnych výsledkov z 3. ... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||||
https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-announces-results-of... | 21 MAR, 2024, 13:57 ET NRx Pharmaceuticals Announces Results of the Vote Held Dur... | NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), ... | 21 MAR, 2024, 13:57 ET | 21 MAR, 2024, 13:57 ET NRx Pharmaceuticals Announces Results of the Vote Held Dur... | NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), ... | 21 MAR, 2024, 13:57 ET NRx Pharmaceuticals Announces Results of the Vote Held Dur... | 21 MAR, 2024, 13:57 ET | 21 MAR, 2024, 13:57 ET NRx Pharmaceuticals Announces Results of the Vote Held Dur... | NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), ... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-to-report-fourth-qua... | 21 MAR, 2024, 16:02 ET NRx Pharmaceuticals to Report Fourth Quarter and Full Year... | NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), ... | 21 MAR, 2024, 16:02 ET | 21 MAR, 2024, 16:02 ET NRx Pharmaceuticals to Report Fourth Quarter and Full Year... | NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), ... | 21 MAR, 2024, 16:02 ET NRx Pharmaceuticals to Report Fourth Quarter and Full Year... | 21 MAR, 2024, 16:02 ET | 21 MAR, 2024, 16:02 ET NRx Pharmaceuticals to Report Fourth Quarter and Full Year... | NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), ... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/ocumension-01477-hk-invests-over-rmb-123... | 21 MAR, 2024, 10:42 ET OcuMension (01477.HK) Invests Over RMB 123.8 Million in Re... | On the evening of March 21st, OcuMension Therapeutics (Shanghai) Co., Ltd. (01477... | 21 MAR, 2024, 10:42 ET | 21 MAR, 2024, 10:42 ET OcuMension (01477.HK) Invests Over RMB 123.8 Million in Re... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | |||||||||||
https://www.prnewswire.com/news-releases/oncohost-wins-2024-artificial-intelligen... | 20 MAR, 2024, 09:00 ET OncoHost Wins 2024 Artificial Intelligence Excellence Awar... | The Business Intelligence Group today announced that OncoHost, a technology compa... | 20 MAR, 2024, 09:00 ET | 20 MAR, 2024, 09:00 ET OncoHost Wins 2024 Artificial Intelligence Excellence Awar... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | |||||||||||
https://www.prnewswire.com/news-releases/parenteral-nutrition-market-global-analy... | 19 MAR, 2024, 18:30 ET Parenteral Nutrition Market Global Analysis and Forecasts ... | The "Parenteral Nutrition Market: Global Industry Analysis, Trends, Market Size, ... | 19 MAR, 2024, 18:30 ET | 19 MAR, 2024, 18:30 ET Parenteral Nutrition Market Global Analysis and Forecasts ... | The "Parenteral Nutrition Market: Global Industry Analysis, Trends, Market Size, ... | 19 MAR, 2024, 18:30 ET Parenteral Nutrition Market Global Analysis and Forecasts ... | 19 MAR, 2024, 18:30 ET | 19 MAR, 2024, 18:30 ET Parenteral Nutrition Market Global Analysis and Forecasts ... | The "Parenteral Nutrition Market: Global Industry Analysis, Trends, Market Size, ... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/payerpro360-by-thelansis--ai-powered-too... | 20 MAR, 2024, 03:26 ET PayerPro360 by Thelansis - AI-Powered Tool Streamlining Pa... | Thelansis Knowledge Partners, specialized in pharmaceutical and biopharmaceutical... | 20 MAR, 2024, 03:26 ET | 20 MAR, 2024, 03:26 ET PayerPro360 by Thelansis - AI-Powered Tool Streamlining Pa... | Thelansis Knowledge Partners, specialized in pharmaceutical and biopharmaceutical... | 20 MAR, 2024, 03:26 ET PayerPro360 by Thelansis - AI-Powered Tool Streamlining Pa... | 20 MAR, 2024, 03:26 ET | 20 MAR, 2024, 03:26 ET PayerPro360 by Thelansis - AI-Powered Tool Streamlining Pa... | Thelansis Knowledge Partners, specialized in pharmaceutical and biopharmaceutical... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/phanes-therapeutics-pt886-granted-fast-t... | 20 MAR, 2024, 18:09 ET Phanes Therapeutics' PT886 granted Fast Track designation ... | Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on i... | 20 MAR, 2024, 18:09 ET | 20 MAR, 2024, 18:09 ET Phanes Therapeutics' PT886 granted Fast Track designation ... | Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on i... | 20 MAR, 2024, 18:09 ET Phanes Therapeutics' PT886 granted Fast Track designation ... | 20 MAR, 2024, 18:09 ET | 20 MAR, 2024, 18:09 ET Phanes Therapeutics' PT886 granted Fast Track designation ... | Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on i... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/pharmacogenomics-research-report-2024-gl... | 19 MAR, 2024, 17:45 ET Pharmacogenomics Research Report 2024: Global Market to Re... | The "Global Pharmacogenomics Market by Offering (Instrument, Consumables, Softwar... | 19 MAR, 2024, 17:45 ET | 19 MAR, 2024, 17:45 ET Pharmacogenomics Research Report 2024: Global Market to Re... | The "Global Pharmacogenomics Market by Offering (Instrument, Consumables, Softwar... | 19 MAR, 2024, 17:45 ET Pharmacogenomics Research Report 2024: Global Market to Re... | 19 MAR, 2024, 17:45 ET | 19 MAR, 2024, 17:45 ET Pharmacogenomics Research Report 2024: Global Market to Re... | The "Global Pharmacogenomics Market by Offering (Instrument, Consumables, Softwar... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/poseida-therapeutics-to-present-at-hc-wa... | 19 MAR, 2024, 16:05 ET Poseida Therapeutics to Present at H.C. Wainwright 2nd Ann... | Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy... | 19 MAR, 2024, 16:05 ET | 19 MAR, 2024, 16:05 ET Poseida Therapeutics to Present at H.C. Wainwright 2nd Ann... | Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy... | 19 MAR, 2024, 16:05 ET Poseida Therapeutics to Present at H.C. Wainwright 2nd Ann... | 19 MAR, 2024, 16:05 ET | 19 MAR, 2024, 16:05 ET Poseida Therapeutics to Present at H.C. Wainwright 2nd Ann... | Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/precigen-reports-full-year-2023-financia... | 19 MAR, 2024, 16:05 ET Precigen Reports Full Year 2023 Financial Results and Busi... | Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the de... | 19 MAR, 2024, 16:05 ET | 19 MAR, 2024, 16:05 ET Precigen Reports Full Year 2023 Financial Results and Busi... | Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the de... | 19 MAR, 2024, 16:05 ET Precigen Reports Full Year 2023 Financial Results and Busi... | 19 MAR, 2024, 16:05 ET | 19 MAR, 2024, 16:05 ET Precigen Reports Full Year 2023 Financial Results and Busi... | Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the de... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/regulus-therapeutics-reports-fourth-quar... | 21 MAR, 2024, 16:05 ET Regulus Therapeutics Reports Fourth Quarter and Year-End 2... | Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on ... | 21 MAR, 2024, 16:05 ET | 21 MAR, 2024, 16:05 ET Regulus Therapeutics Reports Fourth Quarter and Year-End 2... | Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on ... | 21 MAR, 2024, 16:05 ET Regulus Therapeutics Reports Fourth Quarter and Year-End 2... | 21 MAR, 2024, 16:05 ET | 21 MAR, 2024, 16:05 ET Regulus Therapeutics Reports Fourth Quarter and Year-End 2... | Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on ... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/renibus-announces-leadership-transition-... | 21 MAR, 2024, 08:00 ET Renibus Announces Leadership Transition | Renibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company foc... | 21 MAR, 2024, 08:00 ET | 21 MAR, 2024, 08:00 ET Renibus Announces Leadership Transition | Renibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company foc... | 21 MAR, 2024, 08:00 ET Renibus Announces Leadership Transition | 21 MAR, 2024, 08:00 ET | 21 MAR, 2024, 08:00 ET Renibus Announces Leadership Transition | Renibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company foc... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/rx-outreach-builds-first-st-louis-commun... | 19 MAR, 2024, 10:10 ET Rx Outreach builds first St. Louis community pharmacy in p... | Rx Outreach, the country's largest nonprofit digital pharmacy, will host a ribbon... | 19 MAR, 2024, 10:10 ET | 19 MAR, 2024, 10:10 ET Rx Outreach builds first St. Louis community pharmacy in p... | Rx Outreach, the country's largest nonprofit digital pharmacy, will host a ribbon... | 19 MAR, 2024, 10:10 ET Rx Outreach builds first St. Louis community pharmacy in p... | 19 MAR, 2024, 10:10 ET | 19 MAR, 2024, 10:10 ET Rx Outreach builds first St. Louis community pharmacy in p... | Rx Outreach, the country's largest nonprofit digital pharmacy, will host a ribbon... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/sciencemedia-welcomes-visionary-leaders-... | 21 MAR, 2024, 07:30 ET ScienceMedia Welcomes Visionary Leaders to Advisory Board,... | ScienceMedia, a global SaaS provider redefining the landscape of clinical mastery... | 21 MAR, 2024, 07:30 ET | 21 MAR, 2024, 07:30 ET ScienceMedia Welcomes Visionary Leaders to Advisory Board,... | ScienceMedia, a global SaaS provider redefining the landscape of clinical mastery... | 21 MAR, 2024, 07:30 ET ScienceMedia Welcomes Visionary Leaders to Advisory Board,... | 21 MAR, 2024, 07:30 ET | 21 MAR, 2024, 07:30 ET ScienceMedia Welcomes Visionary Leaders to Advisory Board,... | ScienceMedia, a global SaaS provider redefining the landscape of clinical mastery... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/seegene-et-springer-nature-annoncent-les... | 20 MAR, 2024, 00:27 ET Seegene et Springer Nature annoncent les lauréats du progr... | 20 MAR, 2024, 00:27 ET | Seegene et Springer Nature annoncent les lauréats du programme d'open innovation | 20 MAR, 2024, 00:27 ET Seegene et Springer Nature annoncent les lauréats du progr... | 20 MAR, 2024, 00:27 ET Seegene et Springer Nature annoncent les lauréats du progr... | 20 MAR, 2024, 00:27 ET | 20 MAR, 2024, 00:27 ET Seegene et Springer Nature annoncent les lauréats du progr... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||||
https://www.prnewswire.com/news-releases/seegene-y-springer-nature-anuncian-los-g... | 21 MAR, 2024, 03:00 ET Seegene y Springer Nature anuncian los ganadores del Open ... | 21 MAR, 2024, 03:00 ET | Seegene y Springer Nature anuncian los ganadores del Open Innovation Program | 21 MAR, 2024, 03:00 ET Seegene y Springer Nature anuncian los ganadores del Open ... | 21 MAR, 2024, 03:00 ET Seegene y Springer Nature anuncian los ganadores del Open ... | 21 MAR, 2024, 03:00 ET | 21 MAR, 2024, 03:00 ET Seegene y Springer Nature anuncian los ganadores del Open ... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||||
https://www.prnewswire.com/news-releases/senhwa-biosciences-announces-first-patie... | 20 MAR, 2024, 07:00 ET Senhwa Biosciences Announces First Patient Dosed in the Ph... | Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on fir... | 20 MAR, 2024, 07:00 ET | 20 MAR, 2024, 07:00 ET Senhwa Biosciences Announces First Patient Dosed in the Ph... | Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on fir... | 20 MAR, 2024, 07:00 ET Senhwa Biosciences Announces First Patient Dosed in the Ph... | 20 MAR, 2024, 07:00 ET | 20 MAR, 2024, 07:00 ET Senhwa Biosciences Announces First Patient Dosed in the Ph... | Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on fir... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/sgo-2024--the-first-published-clinical-d... | 19 MAR, 2024, 10:00 ET SGO 2024 | The First Published Clinical Data of Nectin-4-T... | Mabwell (688062.SH), an innovative-driven biopharmaceutical company with entire i... | 19 MAR, 2024, 10:00 ET | 19 MAR, 2024, 10:00 ET SGO 2024 | The First Published Clinical Data of Nectin-4-T... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | |||||||||||
https://www.prnewswire.com/news-releases/spolenost-cognizant-nasadi-u-svych-farma... | 19 MAR, 2024, 19:24 ET Společnost Cognizant nasadí u svých farmaceutických klient... | 19 MAR, 2024, 19:24 ET | Společnost Cognizant nasadí u svých farmaceutických klientů technologie generativ... | 19 MAR, 2024, 19:24 ET Společnost Cognizant nasadí u svých farmaceutických klient... | 19 MAR, 2024, 19:24 ET Společnost Cognizant nasadí u svých farmaceutických klient... | 19 MAR, 2024, 19:24 ET | 19 MAR, 2024, 19:24 ET Společnost Cognizant nasadí u svých farmaceutických klient... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||||
https://www.prnewswire.com/news-releases/systech-launches-innovative-exception-ha... | 20 MAR, 2024, 16:15 ET Systech Launches Innovative Exception Handling and Rework ... | Systech, part of Markem-Imaje and Dover and a leading provider of digital identif... | 20 MAR, 2024, 16:15 ET | 20 MAR, 2024, 16:15 ET Systech Launches Innovative Exception Handling and Rework ... | Systech, part of Markem-Imaje and Dover and a leading provider of digital identif... | 20 MAR, 2024, 16:15 ET Systech Launches Innovative Exception Handling and Rework ... | 20 MAR, 2024, 16:15 ET | 20 MAR, 2024, 16:15 ET Systech Launches Innovative Exception Handling and Rework ... | Systech, part of Markem-Imaje and Dover and a leading provider of digital identif... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/topical-corticosteroids-market-to-grow-b... | 21 MAR, 2024, 23:36 ET Topical Corticosteroids Market to Grow by USD 1.08 billion... | The topical corticosteroids market is set to witness substantial growth over the ... | 21 MAR, 2024, 23:36 ET | 21 MAR, 2024, 23:36 ET Topical Corticosteroids Market to Grow by USD 1.08 billion... | 21 MAR, 2024, 23:36 ET | The topical corticosteroids market is set to witness substantial growth over the ... | 21 MAR, 2024, 23:36 ET Topical Corticosteroids Market to Grow by USD 1.08 billion... | 21 MAR, 2024, 23:36 ET | 21 MAR, 2024, 23:36 ET Topical Corticosteroids Market to Grow by USD 1.08 billion... | The topical corticosteroids market is set to witness substantial growth over the ... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | |||||
https://www.prnewswire.com/news-releases/trevi-therapeutics-reports-fourth-quarte... | 20 MAR, 2024, 16:05 ET Trevi Therapeutics Reports Fourth Quarter and Year End 202... | Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical compa... | 20 MAR, 2024, 16:05 ET | 20 MAR, 2024, 16:05 ET Trevi Therapeutics Reports Fourth Quarter and Year End 202... | Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical compa... | 20 MAR, 2024, 16:05 ET Trevi Therapeutics Reports Fourth Quarter and Year End 202... | 20 MAR, 2024, 16:05 ET | 20 MAR, 2024, 16:05 ET Trevi Therapeutics Reports Fourth Quarter and Year End 202... | Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical compa... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/tyra-biosciences-reports-fourth-quarter-... | 19 MAR, 2024, 16:05 ET Tyra Biosciences Reports Fourth Quarter and Full Year 2023... | Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company foc... | 19 MAR, 2024, 16:05 ET | 19 MAR, 2024, 16:05 ET Tyra Biosciences Reports Fourth Quarter and Full Year 2023... | Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company foc... | 19 MAR, 2024, 16:05 ET Tyra Biosciences Reports Fourth Quarter and Full Year 2023... | 19 MAR, 2024, 16:05 ET | 19 MAR, 2024, 16:05 ET Tyra Biosciences Reports Fourth Quarter and Full Year 2023... | Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company foc... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/united-states-pharmacy-benefit-managemen... | 21 MAR, 2024, 21:30 ET United States Pharmacy Benefit Management Market Insights ... | The "U.S. Pharmacy Benefit Management (PBM) Market - Focused Insights 2024-2029" ... | 21 MAR, 2024, 21:30 ET | 21 MAR, 2024, 21:30 ET United States Pharmacy Benefit Management Market Insights ... | The "U.S. Pharmacy Benefit Management (PBM) Market - Focused Insights 2024-2029" ... | 21 MAR, 2024, 21:30 ET United States Pharmacy Benefit Management Market Insights ... | 21 MAR, 2024, 21:30 ET | 21 MAR, 2024, 21:30 ET United States Pharmacy Benefit Management Market Insights ... | The "U.S. Pharmacy Benefit Management (PBM) Market - Focused Insights 2024-2029" ... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/us-fda-approves-idorsias-once-daily-tryv... | 20 MAR, 2024, 08:00 ET US FDA approves Idorsia's once-daily TRYVIO (aprocitentan)... | Idorsia Pharmaceuticals U.S. Inc. announced today that the US Food and Drug Admin... | 20 MAR, 2024, 08:00 ET | 20 MAR, 2024, 08:00 ET US FDA approves Idorsia's once-daily TRYVIO (aprocitentan)... | Idorsia Pharmaceuticals U.S. Inc. announced today that the US Food and Drug Admin... | 20 MAR, 2024, 08:00 ET US FDA approves Idorsia's once-daily TRYVIO (aprocitentan)... | 20 MAR, 2024, 08:00 ET | 20 MAR, 2024, 08:00 ET US FDA approves Idorsia's once-daily TRYVIO (aprocitentan)... | Idorsia Pharmaceuticals U.S. Inc. announced today that the US Food and Drug Admin... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/volition-appoints-dr-andrew-retter-as-ch... | 19 MAR, 2024, 16:30 ET Volition appoints Dr Andrew Retter as Chief Medical Office... | VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigeneti... | 19 MAR, 2024, 16:30 ET | 19 MAR, 2024, 16:30 ET Volition appoints Dr Andrew Retter as Chief Medical Office... | VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigeneti... | 19 MAR, 2024, 16:30 ET Volition appoints Dr Andrew Retter as Chief Medical Office... | 19 MAR, 2024, 16:30 ET | 19 MAR, 2024, 16:30 ET Volition appoints Dr Andrew Retter as Chief Medical Office... | VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigeneti... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/wit-legal-releases-new-report-on-2023-ac... | 20 MAR, 2024, 11:00 ET WIT Legal Releases New Report on 2023 Activities and Trend... | WIT Legal ("WIT"), the leading agency representing testifying experts for high-st... | 20 MAR, 2024, 11:00 ET | 20 MAR, 2024, 11:00 ET WIT Legal Releases New Report on 2023 Activities and Trend... | WIT Legal ("WIT"), the leading agency representing testifying experts for high-st... | 20 MAR, 2024, 11:00 ET WIT Legal Releases New Report on 2023 Activities and Trend... | 20 MAR, 2024, 11:00 ET | 20 MAR, 2024, 11:00 ET WIT Legal Releases New Report on 2023 Activities and Trend... | WIT Legal ("WIT"), the leading agency representing testifying experts for high-st... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/world-precision-instruments-partners-wit... | 20 MAR, 2024, 09:00 ET World Precision Instruments Partners with TotalLab to Intr... | World Precision Instruments (WPI) is pleased to announce their strategic partners... | 20 MAR, 2024, 09:00 ET | 20 MAR, 2024, 09:00 ET World Precision Instruments Partners with TotalLab to Intr... | World Precision Instruments (WPI) is pleased to announce their strategic partners... | 20 MAR, 2024, 09:00 ET World Precision Instruments Partners with TotalLab to Intr... | 20 MAR, 2024, 09:00 ET | 20 MAR, 2024, 09:00 ET World Precision Instruments Partners with TotalLab to Intr... | World Precision Instruments (WPI) is pleased to announce their strategic partners... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | ||||||
https://www.prnewswire.com/news-releases/wykorzystujc-nvidia-bionemo-firma-cogniz... | 19 MAR, 2024, 10:51 ET Wykorzystując NVIDIA BioNeMo, firma Cognizant zamierza zas... | 19 MAR, 2024, 10:51 ET | Wykorzystując NVIDIA BioNeMo, firma Cognizant zamierza zastosować generatywną szt... | 19 MAR, 2024, 10:51 ET Wykorzystując NVIDIA BioNeMo, firma Cognizant zamierza zas... | 19 MAR, 2024, 10:51 ET Wykorzystując NVIDIA BioNeMo, firma Cognizant zamierza zas... | 19 MAR, 2024, 10:51 ET | 19 MAR, 2024, 10:51 ET Wykorzystując NVIDIA BioNeMo, firma Cognizant zamierza zas... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/... | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC | 2024-03-22 05:27:45 UTC |
Sample code snippets to quickly import data set into your application
For more information on how to automatically trigger an import please reference our WebHook API guide
Integrating with Java
import java.io.BufferedReader; import java.io.InputStreamReader; import java.net.URL; import java.net.URLConnection; import java.util.Arrays; public class HelloWorld { public static void main(String[] args) { try { URL urlCSV = new URL( "https://cache.getdata.io/n129689_754199c098e7114d0e7f9b72f41a3c52eses/latest_all.csv" ); URLConnection urlConn = urlCSV.openConnection(); InputStreamReader inputCSV = new InputStreamReader( ((URLConnection) urlConn).getInputStream() ); BufferedReader br = new BufferedReader(inputCSV); String line; String[] fields; while ((line = br.readLine()) != null) { // Each row fields = line.split(","); System.out.println(Arrays.toString(fields)); } // clean up buffered reader br.close(); } catch (Exception e) { System.out.println(e.getMessage()); } } }
Integrating with NodeJs
const csv = require('csv-parser'); const https = require('https'); const fs = require('fs'); const file = fs.createWriteStream("temp_download.csv"); const request = https.get( "https://cache.getdata.io/n129689_754199c098e7114d0e7f9b72f41a3c52eses/latest_all.csv", function(response) { response.pipe(file); } ); file.on('finish', function() { file.close(); fs.createReadStream('temp_download.csv').pipe(csv()).on('data', (row) => { // Each row console.log(row); }).on('end', () => { console.log('CSV file successfully processed'); }); });
Integrating with PHP
$data = file_get_contents("https://cache.getdata.io/n129689_754199c098e7114d0e7f9b72f41a3c52eses/latest_all.csv"); $rows = explode("\n",$data); $s = array(); foreach($rows as $row) { # Each row var_dump( $row); }
Integrating with Python
import csv import urllib2 url = 'https://cache.getdata.io/n129689_754199c098e7114d0e7f9b72f41a3c52eses/latest_all.csv' response = urllib2.urlopen(url) cr = csv.reader(response) for row in cr: # Each row print row
Integrating with Ruby
require 'open-uri' require 'tempfile' require 'csv' temp_file = Tempfile.new( "getdata", :encoding => 'ascii-8bit') temp_file << open("https://cache.getdata.io/n129689_754199c098e7114d0e7f9b72f41a3c52eses/latest_all.csv").read temp_file.rewind CSV.foreach( open(uri), :headers => :first_row ).each do |row| # Each row puts row end